Johnson & Johnson's Fiscal Year is From January To December - All Figures are in Percent.
The item "Operating-Return-On-Assets" stands at 12.66 percent as of 09/30/2025.
As of the end of Johnson & Johnson's third quarter, the item "Operating Return On Assets" stands at 12.66 Percent. This represents an increase of 0.73 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -0.4016 percentage points compared to the value the year prior.
The 1 year change in percentage points is -0.4016.
The 3 year change in percentage points is -0.1797.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Operating Return On Assets | 905,699,262,464.00 |
![]() | AbbVie Inc - Operating Return On Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Operating Return On Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Operating Return On Assets | 280,205,508,085.11 |
![]() | Novartis AG - Operating Return On Assets | 255,096,620,580.91 |